Sort
50,496 grants matching “lung cancer”
Ambient Particle Radioactivity and Lung Cancer Survival
$433,185David C Christiani · Harvard University D/B/A Harvard School Of Public Health · R21 · FY2025 · ES
Technologies and Resources for Core Laboratories
$433,182Laura F Gibson · West Virginia University · U54 · FY2021 · GM
Lung Tumor Promotion by BHT
$433,116Alvin M Malkinson · University Of Colorado Denver · R01 · FY2006 · CA
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities
$433,114Sharon R. Pine · University Of Colorado Denver · R01 · FY2025 · CA
Lung Cancer Vaccine
$433,048Nasser Khaled Altorki · Weill Medical Coll Of Cornell Univ · U54 · FY2025 · CA
Training in Translational Research of Lung, Head and Neck Cancer
$433,044Xiao-Jing Wang · University Of Colorado Denver · T32 · FY2015 · CA
The influence of selenium on biomarkers of prostate cancer risk
$433,034Karam E El-Bayoumy · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
Role of TbRIII in Regulating Motility and Invasion
$433,023Gerard C Blobe · Duke University · R01 · FY2009 · CA
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
$432,955Eric Collisson · University Of California, San Francisco · R01 · FY2019 · CA
Experimental Cancer Imaging Research Program (ECIRP)
$432,926John D Hazle · University Of Tx Md Anderson Can Ctr · U24 · FY2007 · CA
Leveraging deep learning for markerless motion management in radiation therapy
$432,907Lei Xing · Stanford University · R01 · FY2025 · CA
Effect of Prone Position on Ventilator-Induced Lung Injury
$432,891Guido Musch · Massachusetts General Hospital · R01 · FY2010 · HL
Image guided immunotherapy and targeted radionuclide therapy of metastatic melanoma
$432,877Carolyn J Anderson · University Of Missouri-Columbia · R01 · FY2021 · CA
Determinants and Outcomes of Nicotine Metabolite Ratio in HIV + Smokers
$432,874Robert Gross · University Of Pennsylvania · R01 · FY2022 · HL
BWS and Embryonal Tumor Suppressor Genes on 11p15
$432,836Andrew P Feinberg · Johns Hopkins University · R37 · FY2008 · CA
Integrative genomic analysis of the human response to glucocorticoids
$432,807Luis M Franco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Hexokinase 2 in liver cancer
$432,799Nissim Hay · University Of Illinois At Chicago · R01 · FY2020 · CA
Elucidating the Cellular Origins of lung adenocarcinoma
$432,749Crystal Nicole Marconett · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Novel therapy targeting refractory colon cancer
$432,692Ping-Ying Pan · Methodist Hospital Research Institute · R01 · FY2018 · CA
Regulation of tumor-infiltrating T cells by macrophages
$432,678Yiping Yang · Ohio State University · R01 · FY2022 · CA
Regulation of tumor-infiltrating T cells by macrophages
$432,678Yiping Yang · Ohio State University · R01 · FY2023 · CA
Tumor-specific autoantibodies for SCLC early detection
$432,640A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Development of Drugs Acting at Ion Channels
$432,633Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Disruption of the circadian clock in lung cancer
$432,625Brian James Altman · University Of Rochester · R01 · FY2024 · CA
Technologies and Resources for Core Laboratories
$432,608Laura F Gibson · West Virginia University · U54 · FY2017 · GM